Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...
1h
The global cardiovascular devices market, valued at US$ 72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, reaching US$ ...
Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback